
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a recent study published in the journal Pediatrics looked at the impact on health of being in the foster care system.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a recent study published in the journal Pediatrics that looked at the impact on health of being in the foster care system.






